News Search

Faculty who received promotions, endowed professorships, and awards in the 2024-2025 fiscal year were honored.

Sadelain was elected for pioneering scientific studies that laid the groundwork for chimeric antigen receptor T cell (CAR-T) immunotherapy for cancer and for advancing its clinical application.

A peptide designed by Columbia researchers helps the immune system recognize and attack stomach cancer in mice and represents a promising new strategy for patients with gastric and other tumors.

Drugs already in development may have the potential to block the chemical and help people exposed to trauma in childhood, who do not often respond to SSRIs.